FDA warns about numbing teething products, asks manufacturers to stop selling them for young children

The FDA has warned that it will sue manufacturers that voluntarily stop selling benzocaine products for young children.

The Food and Drug Administration (FDA) has warned parents about using teething products that contain the numbing agent benzocaine, according to USA Today. The FDA has also asked manufacturers to stop selling these products for toddlers and babies.

According to the FDA, these numbing gel and cream products have rare but deadly side effects for children. They can especially affect those under two years old.

While the FDA has warned about these teething products in the past, both illnesses and death from use have continued. This time, the FDA is requesting a ban on selling the products to the market asserting that there is no evidence that they actually work.

Manufacturers that do not voluntarily remove the product for young children will face legal action from the FDA. The FDA also wants these manufacturers to take action immediately to comply with its request.

The drug benzocaine is sold over-the-counter to aid in toothaches and cold sores for adults in products like Orajel and Anbesol. Even though these products will remain on the market, the FDA wants companies to add warnings to them for adult use.

The drug benzocaine can cause a rare blood condition that has been linked to breathing problems, which can be deadly. Symptoms of the illness include shortness of breath, headache, and rapid heart rate.

Leave a Reply

Your email address will not be published. Required fields are marked *